Scoggin »

Neumora Therapeutics shares owned by Scoggin

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Scoggin from 13F filings

Historical chart of Scoggin investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Scoggin consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Scoggin

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 125k 17.05
2023-09-30 $2.1M 150k 14.11

More positions owned by Scoggin

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Apollo Global Mgmt (APO)
Element Solutions (ESI)
Telephone & Data Sys Com New (TDS)
Soho House & Co Com Cl A (SHCO)
Advisorshares Tr Pure Us Cannabis (MSOS)
Arbor Realty Trust (ABR)
Verizon Communications (VZ)
Kenvue Call Option (KVUE)
Alphabet Cap STK CL C (GOOG)
United States Steel Corporation (X)
Walt Disney Company Call Option (DIS)

View all positions for Scoggin

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Avidity Partners Management
Citadel Advisors
Hillhouse Capital Advisors
OrbiMed Advisors
Goldman Sachs Group
Logos Global Management
Vanguard Group
Addis & Hill
Schonfeld Strategic Advisors
Pier Capital

View all funds holding Neumora Therapeutics